CatalystMarker
← board

MTEX

distress 0/10 · well-funded / low risk
$4.38-4%today-57% from 52w high
mannatech.com170 employeesFounded 1993Flower Mound, TXFood Distribution
Revenue
$25M
Liquidity
$7M
Runway
9.3 yrs
Shares 1y
+2%

Price & events

-42.1% over 6M
$3.95$5.82$7.69Jan 26Apr 26Jul 26779k
CatalystRating changeDilutionFinancingdashed = today
-4.4%
1D
-7.0%
1W
-18.9%
1M
-6.8%
3M
-42.1%
6M
-47.4%
1Y
-37.4%
2Y
-83.1%
5Y
-73.4%
All

Overview

Market Cap
$8.45M
Enterprise Value
$4.19M
Volume
17.80K
52 Week Range
$3.95 – $10.19
Total Shares
1.93M
Float Shares
937.92K
Short %
1.07%
% Held by Insiders
56.21%
% Held by Institutions
16.87%
RVOL
1.35x
Beta
0.71

Pipeline · 0 trials · 0 upcoming

ReadoutPhaseDrugIndicationEnrollStatus
No pipeline trials tracked.

Catalyst news & presentations · 1

Approved drugs (0)

  • none — clinical-stage

Capital structure — dilution & financing

Shares out: 1,929,670 · 0 offerings/1y · 0 PIPEs
  • 2025-09-128-Kmaterial_agreement
  • 2024-11-01SC 13Gstrategic_stake
  • 2024-07-028-Kmaterial_agreement
🔒 Positioning — Pro
Short interest / days-to-cover, insider buys & sells.
Upgrade to Pro
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to Pro

Wall St ratings

no consensus
  • no recent rating changes

Competitors

  • none identified

Recent news

  • none

Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.